<DOC>
	<DOCNO>NCT00895947</DOCNO>
	<brief_summary>The aim study see lozenge contain low dose interferon-alpha prevent and/or reduce severity cold flu . Starting 1 month expect start winter cold flu season Perth , Australia , healthy volunteer allow lozenge contain interferon , lozenge contain medicine ( placebo ) , dissolve mouth day 16 week . Blood test start end treatment determine whether interferon able prevent infection cold/flu virus . Once week , volunteer complete survey cold/flu symptom , medication take , day work miss , etc . see interferon able make winter cold flu less severe .</brief_summary>
	<brief_title>Interferon Alpha Lozenges Prevention Winter Colds Flu</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Male nonpregnant female Females childbearing potential must practice medically accept form birth control Currently exhibit acute upper respiratory tract infection history chronic respiratory disease require regular therapy ( i.e . COPD , asthma , bronchitis , etc . ) condition likely increase risk severe complicate influenza ( i.e . cardiac disease , chronic renal disease , endocrine disease , include diabetes and/or immunosuppressive therapy ) condition require regular treatment antihistamine , analgesic antipyretic know infection HIV , hepatitis B virus hepatitis C virus serious , uncontrolled disease active infection require use antibiotic antiviral drug nonambulatory status suspect drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Prophylaxis</keyword>
	<keyword>Treatment</keyword>
	<keyword>Symptoms</keyword>
	<keyword>Winter Colds Flu</keyword>
</DOC>